Home > Boards > US Listed > Biotechs > Sesen Bio (SESN)

picked up some recently in the low .70's.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rivervalley Member Profile
 
Followed By 53
Posts 5,257
Boards Moderated 0
Alias Born 05/24/11
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 4:08:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 7:34:46 AM
Sesen Bio Reports Third Quarter 2020 Financial Results & Positive Progress Towards Completing the BLA Submission for Vicineum... Business Wire - 11/9/2020 7:30:00 AM
Sesen Bio to Host Conference Call to Review Third Quarter Financial Results & Provide an Update on Positive Progress Towards ... Business Wire - 11/2/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2020 4:07:51 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2020 4:03:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/26/2020 8:03:12 AM
Sesen Bio Announces Successful Pre-Submission Meeting with the European Medicines Agency for Vicineumâ„¢ Business Wire - 10/26/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/19/2020 8:03:14 AM
Sesen Bio Announces an Exclusive Agreement With Cardinal Health for Third-Party Logistics & Specialty Pharmaceutical Distribu... Business Wire - 10/19/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 8:01:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2020 8:02:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2020 8:02:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/28/2020 8:01:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 8:03:35 AM
Sesen Bio to Provide Business Update at the H. C. Wainwright 22nd Annual Global Investment Conference Business Wire - 9/8/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/24/2020 7:16:09 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:21:26 PM
Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update Business Wire - 8/10/2020 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/7/2020 7:30:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 5:03:26 PM
Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference Business Wire - 8/5/2020 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 8:01:01 AM
Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development & commercialization of Vicine... Business Wire - 7/31/2020 7:30:00 AM
Sesen Bio to Host Conference Call to Provide OUS Business Update Business Wire - 7/30/2020 8:00:00 AM
rivervalley   Saturday, 11/25/17 07:43:57 AM
Re: None
Post # of 6037 
picked up some recently in the low .70's. Waiting for a move back up to and hopefully past $1. CLSN has been one of the best traders I've had lately but also playing 6-7 others.

Posts are my opinion only and not to be considered as investment advice to others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences